Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/19676

Title: Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infections
Authors: Stappers, Mark
Hagen, F.
Reimnitz, P.
Mouton, J. W.
Meis, J. F.
Gyssens, Inge
Issue Date: 2015
Publisher: SPRINGER
Abstract: Major abscesses and diabetic foot infections (DFIs) are predominant subtypes of complicated skin and skin structure infections (cSSSIs), and are mainly caused by Staphylococcus aureus and beta-hemolytic streptococci. This study evaluates the potential benefit of direct pathogen-specific real-time polymerase chain reaction (PCR) assays in the identification of causative organisms of cSSSIs. One-hundred and fifty major abscess and 128 DFI biopsy samples were collected and microbial DNA was extracted by using the Universal Microbe Detection kit for tissue samples. Pathogen-specific PCRs were developed for S. aureus and its virulence factor Panton-Valentine leukocidin (PVL), Streptococcus pyogenes, S. agalactiae, S. dysgalactiae, and the S. anginosus group. Identification by pathogen-specific PCRs was compared to routine culture and both methods were considered as the gold standard for determination of the sensitivity and specificity of each assay. Direct real-time PCR assays of biopsy samples resulted in a 34 % higher detection of S. aureus, 37 % higher detection of S. pyogenes, 18 % higher detection of S. agalactiae, 4 % higher detection of S. dysgalactiae subspecies equisimilis, and 7 % higher detection of the S. anginosus group, compared to routine bacterial culture. The presence of PVL was mainly confined to S. aureus isolated from major abscess but not DFI biopsy samples. In conclusion, our pathogen-specific real-time PCR assays had a higher yield than culture methods and could be an additional method for the detection of relevant causative pathogens in biopsies.
Notes: [Stappers, M. H. T.; Gyssens, I. C.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands. [Stappers, M. H. T.; Hagen, F.; Meis, J. F.; Gyssens, I. C.] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands. [Stappers, M. H. T.; Gyssens, I. C.] Hasselt Univ, Hasselt, Belgium. [Reimnitz, P.] Bayer Healthcare Pharmaceut, Wuppertal, Germany. [Mouton, J. W.; Meis, J. F.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands. [Mouton, J. W.; Meis, J. F.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
URI: http://hdl.handle.net/1942/19676
DOI: 10.1007/s10096-015-2428-4
ISI #: 000360223400021
ISSN: 0934-9723
Category: A1
Type: Journal Contribution
Validation: ecoom, 2016
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
N/A296.48 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.